BOCA RATON, FL – January 28, 2025
CMM Launches $497 Market Intelligence Tool for Medical Practices
1 min read Premium comments
OTWPRCustom Medical MarketingPractice-Market FitSeth Turnoff
Custom Medical Marketing introduced Practice-Market Fit, a strategic assessment tool designed to provide medical practices with market intelligence at an accessible price point.
The product addresses a sequence problem in healthcare practice growth, according to CMM founder Seth Turnoff: practices often invest in marketing tactics without understanding their competitive position or operational readiness.
“A group would come to us asking for patient acquisition campaigns without assessing whether their market position, internal systems, or digital visibility actually supported those tactics,” Turnoff said. “They were making six-figure marketing decisions with no strategic diagnostic information.”
Practice-Market Fit delivers custom market intelligence reports within 48 hours for $497. Each assessment evaluates market demand, competitive positioning, digital visibility, AI search readiness, and patient access friction points.
The framework was developed from CMM’s work with orthopedic and cardiac practices ranging from $5 million to $150 million in revenue. Unlike automated SEO audits, each report is created specifically for the requesting practice’s specialty and competitive context.
CMM designed the product as a standalone transaction, not a lead-generation tool. Practices receive strategic intelligence with no obligation for additional services, filling that gap between enterprise-level healthcare consulting and commodity-level website audits.
The tool benefits individual specialists, specialty practices in competitive markets, PE-backed groups and practice leaders evaluating expansion or new service lines.
More information available at https://practicemarketfit.com/
###
About
Custom Medical Marketing (CMM) is a strategic consulting firm that provides market intelligence and patient acquisition services to medical practices. Founded in 2019, the company works primarily with specialty practices in competitive markets, using proprietary frameworks to assess competitive positioning and identify growth opportunities.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.